Viewing Study NCT06481592


Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2026-02-25 @ 6:59 PM
Study NCT ID: NCT06481592
Status: RECRUITING
Last Update Posted: 2025-10-30
First Post: 2024-06-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
Sponsor: Iovance Biotherapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Endometrial Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tumor Infiltrating Lymphocytes View
None TIL View
None Endometrial Cancer View
None Endometrial View
None Cell Therapy View
None Cellular Immunotherapy View
None IL-2 View
None Non-myeloablative lymphodepletion (NMALD) View